Apoptosis following interleukin-2 withdrawal from T cells: Evidence for a regulatory role of CD18 (β2-integrin) molecules

Tissue Antigens

Volumn 48, Issue 2, 1996, Pages 127-135

  Ropke C ^a   Gladstone, P ^c   Nielsen, M ^a   Borregaard, N ^b   Ledbetter, J A ^c   Svejgaard, A ^b   Odum N ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b University of Copenhagen   (Denmark)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

Apoptosis; Cytokine deprivation; Interleukin 15; Interleukin 2; LFA 1

Indexed keywords

CD18 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 2; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;

APOPTOSIS; ARTICLE; CASE REPORT; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0029840011     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1996.tb02617.x     Document Type: Article

References (38)

1. Cohen JJ. Programmed cell death in the immune system. Adv Immunol 1991: 50: 55-85.
2. Penninger JM, Mak TW. Signal transduction, mitogenetic catastrophes, and death in T-cell development. Immunol Rev 1994: 142: 231-272.
3. Ucker DS, Hebshi LD, Blomquist JF, Torbett BE. Physiological T-cell death: susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant. Immunol Rev 1994: 142: 273-298.
4. Duke RC, Cohen JJ. IL-2 addiction: Withdrawal of growth factor activates a suicide program in dependent T cells. Lymphokine Cytokine Res 1986: 5: 289-299.
5. Springer TA. Adhesion receptors of the immune system. Nature (London) 1990: 346: 425-434.
6. Matsumoto Y, Hiromatsu K, Sakai T et al. Co-stimulation with LFA-1 triggers apoptosis in gamma delta T cells on T cell receptor engagement. Eur J Immunol 1994: 24: 2441-2445.
7. Pircher H, Muller KP, Kyewski BA, Hengartner H. Thymocytes can tolerize thymocytes by clonal deletion in vitro. Int Immunol 1992: 4: 1065-1069.
8. Damle N-K, Leytze G, Klussman K, Ledbetter J-A. Activation with superantigens induced programmed death in antigen primed CD4+ class II+ major histocompatibility complex T lymphocytes via a CD11a/CD18-dependent mechanism. Eur J Immunol 1993: 23: 1513-1522.
9. Ishii N, Takeshita T, Kimura Y et al. Expression of the IL-2 receptor gamma chain on various populations in human peripheral blood. Int Immunol 1994: 6: 1273-1277.
10. Damle N, Klaussman K, Linsley PS, Aruffo A, Ledbetter JA. Differential regulatory effects of ICAM-1 on co-stimulation by the CD28 counter-receptor B7. J Immunol 1992: 149: 2541-2548.
11. Ødum N, Ledbetter JA, Martin P, Geraghty D, Hansen JA, Gladstone P. Homotypic aggregation of human cell lines by HLA class II, class Ia, and HLA-G specific monoclonal antibodies. Eur J Immunol 1991: 21: 2121-2131.
12. Ødum N, Hartzman R, Jakobsen B-K et al. The HLA-DP polymorphism in Denmark investigated by local and international PLT reagents. Definition of two "new" DP antigens. Tissue Antigens 1986: 28: 105-118.
13. Nielsen M, Ødum N, Bendtzen K, Ryder L-P, Jakobsen B-K, Svejgaard A. MHC class II molecules regulate growth in human T cells. Exp Clin Immunogenet 1994: 11: 23-32.
14. Ødum N, Kanner SB, Ledbetter JA, Svejgaard A. MHC class II molecules deliver co-stimulatory signals in human T cells through a functional linkage with IL2 receptors. J Immunol 1993: 150: 5289-5298.
15. Nielsen M, Svejgaard A, Röpke C, Nordahl M, Ødum N. Staphyloccal enterotoxins modulate interleukin-2 receptor expression and ligand induced tyrosine phosphorylation of the Janus kinase 3 and STAT proteins. Proc Natl Acad Sci U S A 1995: 92: 10995-10999.
16. Giri JG, Ahdieh M, Eisenman J et al. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 1994: 13: 2822-2830
17. Giri JG, Kumaki S, Ahdieh M etal. Identification and cloning of a novel IL-15 binding protein that is structually related to the alpha chain of the IL-2 receptor. EMBO J 1995: 14: 3654-3663.
18. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukocyte Biol 1995: 57: 763-766.
19. Clerici M, Sarin A, Coffman RL et al. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc Natl Acad Sci U S A 1994: 91: 11811-11815
20. Damle NK, Klaussman K, Leytze G, Aruffo A, Linsley PS, Ledbetter JA. Costimulation with integrin ligands intercellular adhesion molecule-1 or vascular cell adhesion molecule-1 augments activation induced death of antigen-specific CD4+ T lymphocytes. J Immunol 1993: 151: 2368-2379.
21. Crispe N. Fatal interactions: Fas-induced apoptosis of mature T cells. Immunity 1994: 1: 347-349.
22. Glickstein LJ, Huber BT. Karoushi-death by overwork in the immune system. J Immunol 1995: 155: 6-8.
23. Damle NK, Klussman K, Aruffo A. ICAM-2, a second ligand for CD11a/CD18 (LFA-1). provides a costimulatory signal for T cell receptor-initiated activation of human T cells. J Immunol 1992: 148: 665-671.
24. Del Pozo MA, Campanero MR, Sanchez-Mateos P et al. Role of ICAM-3 in intercellular adhesion and activation of T lymphocytes. Cell Adhesion Commun 1994: 2: 211-218.
25. Ødum N, Yoshizumi H, Okamoto Y et al. Signal transduction through HLA-class II molecules in activated human T cells: induction of homotypic aggregation. Hum Immunol 1992: 35: 71-84.
26. de Foungerolles AR, Springer TA. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function associated molecule 1 on resting lymphocytes. J Exp Med 1992: 175: 185-190.
27. King PD, Sandberg ET, Selvakumar A, Fang P, Beaudet AL, Dupont B. Novel isoforms of murine intercellular adhesion molecule-1 generated by alternative splicing. J Immunol 1995: 154: 6080-6093.
28. Crowley CA, Curnutte JT, Rosin RE et al. An inherited abnormality of neutrophil adhesion. Its genetic transmission and its association with a missing protein. N Engl J Med 1980: 302: 1163-1168.
29. Arnaout MA, Pitt J, Cohen HJ, Melamed J, Rosen FS, Colten HRN. Deficiency of a granulocyte-membrane glycoprotein (gp150) in a boy with recurrent bacterial infections. N Engl J Med 1982: 306: 693-699.
30. Dana N, Todd RF, Pitt J, Springer TA, Arnaout MA. Deficiency of a surface membrane glycoprotein (mol) in man. J Clin Invest 1984: 73: 153.
31. Springer TA, Thompson WS, Miller LJ, Schmalsteig FC, Anderson DC. Inherited deficiency of the Mac-1, LFA-1, p150,90 glycoprotein family and its molecular basis. J Exp Med 1984: 160: 1901-1918.
32. Arnaout MA, Spits H, Terhorst C, Pitt J, Tod RF. Deficiency of a leukocyte surface glycoprotein (LFA-1) in two patients with Mol deficiency. Effects of cell activation on Mol/ LFA-1 surface expression in normal and deficient leukocytes. J Clin Invest 1984: 74: 1291-1300.
33. Arnaout MA. Leukocyte adhesion molecules deficiency: its structural basis, pathophysiology and implications for modulating the inflammatory response. Immunol Rev 1990: 114: 145-180.
34. Vennegoor CJGM, va de Wiel-van Kemenade E, Huijbens RJF, Sanchez-Madrid F, Melief CJM, Figdor CG. Role of LFA-1 and VLA-4 in adhesion of cloned normal and LFA-1 (CD11a/CD18)-deficient T cells to cultured endothelial cells. J Immunol 1992: 148: 1093-1101.
35. Ødum N, Hofmann B, Morling N et al. Differences between primed allogeneic T-cell responses and the primary mixed leukocyte reaction: primed T cells become independent of the blocking effects of monoclonal antibodies against IL1b and the CDS. CD11a (LFA-1). and CD11c (p150,90) molecules. Scand J Immunol 1988: 27: 405-11.
36. Raff M C. Social control on cell survival and cell death. Nature (London) 1992: 356: 397-400.
37. White E. Death-defying acts: a meeting review on apoptosis. Genes Dev 1993: 7: 2277-2284.
38. Boudreau N, Sympson CJ, Werb Z, Bissel MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995: 267: 891-893.